A federally-backed, non-dilutive commercialisation program for growth-stage Australian digital-health startups.
- The offer:
- $5M per company
- Location:
- Remote
- Duration:
- 104 weeks
What you need to qualify
- Digital or connected health SME that has reached proof of concept.
- Evidence-based, with demonstrable potential for commercial and clinical impact.
- Ready to commercialise, seek investors and expand into new markets.
- Able to run a milestone-based project of up to 24 months across two stages, Stage 1 of 4 to 6 months and Stage 2 of 14 to 18 months.
- Competitive: up to five companies are selected per intake by a multi-sectoral, multi-disciplinary group of industry leaders.
Eligibility
- Eligible stages
- All stages
- Countries
- Global, subject to the provider’s eligibility and approval
Frequently asked
Up to AUD 5 million in non-dilutive project funding, tranched according to agreed milestones, with no equity requirements or IP transfer. The programme runs up to 24 months across two stages: Stage 1 of 4 to 6 months and Stage 2 of 14 to 18 months.
Proof-of-concept-stage, evidence-based digital and connected health SMEs with demonstrable commercial and clinical impact potential that are ready to commercialise, seek investors and expand into new markets.
No. ANDHealth publishes "Program status: closed" on the programme page. Intake one ran from 2 September 2025 to 16 January 2026 and its five awardees were announced on 25 May 2026. ANDHealth states that applications for the next intake are expected to open in August 2026, without publishing an exact date.
Up to five companies per intake, selected through a competitive assessment process run by a multi-sectoral, multi-disciplinary group of industry leaders experienced in evaluating high-potential SMEs. There are three intakes in total under the MRFF BioMedTech Incubator 2024 funding.
ANDHealth does not publish an application form, portal or step-by-step process on the ANDHealth+ page. Applications only exist while an intake is open, so the programme page is where the next window is announced.
No. Masterclass: ACCELERATE is a separate six-day intensive, capped at 30 participants, free for ANDHealth members and companies with fewer than 10 employees and AUD 950 excluding GST for larger industry applicants. It is described as a preparation pathway to the ANDHealth+ flagship, not the flagship itself.
Digital healthConnected health